A

Abeona Therapeutics
D

ABEO

5.98000
USD
0.20
(3.46%)
Market Closed
Volume
12,059
EPS
-2
Div Yield
-
P/E
-3
Market Cap
259,956,759
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    Q
    QURE
    -0.55000
    (-8.14%)
    6.21000 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    R
    RGNX
    -1.51500
    (-13.60%)
    9.62500 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    V
    VYGR
    -0.57000
    (-9.18%)
    5.64000 USD
    More
News

Title: Abeona Therapeutics

Sector: Healthcare
Industry: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.